134 related articles for article (PubMed ID: 11525773)
1. A novel neurotensin analog blocks cocaine- and D-amphetamine-induced hyperactivity.
Boules M; Warrington L; Fauq A; McCormick D; Richelson E
Eur J Pharmacol; 2001 Aug; 426(1-2):73-6. PubMed ID: 11525773
[TBL] [Abstract][Full Text] [Related]
2. Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier.
Boules M; McMahon B; Wang R; Warrington L; Stewart J; Yerbury S; Fauq A; McCormick D; Richelson E
Brain Res; 2003 Oct; 987(1):39-48. PubMed ID: 14499944
[TBL] [Abstract][Full Text] [Related]
3. Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats.
Fredrickson P; Boules M; Yerbury S; Richelson E
Eur J Pharmacol; 2003 Jan; 458(1-2):111-8. PubMed ID: 12498914
[TBL] [Abstract][Full Text] [Related]
4. Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol.
Cusack B; Boules M; Tyler BM; Fauq A; McCormick DJ; Richelson E
Brain Res; 2000 Feb; 856(1-2):48-54. PubMed ID: 10677610
[TBL] [Abstract][Full Text] [Related]
5. Induction of tolerance to the suppressant effect of the neurotensin analogue NT69L on amphetamine-induced hyperactivity.
Hertel P; Byskov L; Didriksen M; Arnt J
Eur J Pharmacol; 2001 Jun; 422(1-3):77-81. PubMed ID: 11430916
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys.
Fantegrossi WE; Ko MC; Woods JH; Richelson E
Pharmacol Biochem Behav; 2005 Feb; 80(2):341-9. PubMed ID: 15680187
[TBL] [Abstract][Full Text] [Related]
7. Highly potent neurotensin analog that causes hypothermia and antinociception.
Tyler-McMahon BM; Stewart JA; Farinas F; McCormick DJ; Richelson E
Eur J Pharmacol; 2000 Feb; 390(1-2):107-11. PubMed ID: 10708713
[TBL] [Abstract][Full Text] [Related]
8. NT79: A novel neurotensin analog with selective behavioral effects.
Boules M; Liang Y; Briody S; Miura T; Fauq I; Oliveros A; Wilson M; Khaniyev S; Williams K; Li Z; Qi Y; Katovich M; Richelson E
Brain Res; 2010 Jan; 1308():35-46. PubMed ID: 19874804
[TBL] [Abstract][Full Text] [Related]
9. Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats.
Boules M; Warrington L; Fauq A; McCormick D; Richelson E
Eur J Pharmacol; 2001 Oct; 428(2):227-33. PubMed ID: 11675040
[TBL] [Abstract][Full Text] [Related]
10. Novel neurotensin analog blocks the initiation and expression of nicotine-induced locomotor sensitization.
Fredrickson P; Boules M; Yerbury S; Richelson E
Brain Res; 2003 Jul; 979(1-2):245-8. PubMed ID: 12850594
[TBL] [Abstract][Full Text] [Related]
11. A neurotensin analog blocks cocaine-conditioned place preference and reinstatement.
Boules M; Netz R; Fredrickson PA; Richelson E
Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):236-9. PubMed ID: 26901162
[TBL] [Abstract][Full Text] [Related]
12. Repeated administration of the neurotensin analogue NT69L induces tolerance to its suppressant effect on conditioned avoidance behaviour.
Hertel P; Olsen CK; Arnt J
Eur J Pharmacol; 2002 Mar; 439(1-3):107-11. PubMed ID: 11937099
[TBL] [Abstract][Full Text] [Related]
13. The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition.
Shilling PD; Richelson E; Feifel D
Behav Brain Res; 2003 Jul; 143(1):7-14. PubMed ID: 12842291
[TBL] [Abstract][Full Text] [Related]
14. Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance.
Briody S; Boules M; Oliveros A; Fauq I; Richelson E
Behav Brain Res; 2010 Feb; 207(1):118-24. PubMed ID: 19800922
[TBL] [Abstract][Full Text] [Related]
15. The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat.
Boules M; Iversen I; Oliveros A; Shaw A; Williams K; Robinson J; Fredrickson P; Richelson E
Brain Res; 2007 Jan; 1127(1):90-8. PubMed ID: 17113052
[TBL] [Abstract][Full Text] [Related]
16. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E
Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313
[TBL] [Abstract][Full Text] [Related]
17. The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex.
Li Z; Boules M; Williams K; Peris J; Richelson E
Brain Res; 2010 Jan; 1311():28-36. PubMed ID: 19948149
[TBL] [Abstract][Full Text] [Related]
18. A neurotensin analog, NT69L, attenuates intravenous nicotine self-administration in rats.
Boules M; Oliveros A; Liang Y; Williams K; Shaw A; Robinson J; Fredrickson P; Richelson E
Neuropeptides; 2011 Feb; 45(1):9-16. PubMed ID: 21047685
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
[TBL] [Abstract][Full Text] [Related]
20. A novel neurotensin peptide analog given extracranially decreases food intake and weight in rodents.
Boules M; Cusack B; Zhao L; Fauq A; McCormick DJ; Richelson E
Brain Res; 2000 May; 865(1):35-44. PubMed ID: 10814731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
